China: 111 to launch online diabetes platform with Lilly China

Shanghai-based digital and mobile healthcare platform 111 has launched a new diabetes patient management platform in cooperation with Lilly China. The two companies will work together to build a comprehensive diabetes patient management platform that includes services such as disease management, disease education and patient support programmes to enrich patients’ knowledge of chronic disease management…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »